{"id":849123,"date":"2023-01-05T18:01:17","date_gmt":"2023-01-05T17:01:17","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/"},"modified":"2023-01-05T18:01:17","modified_gmt":"2023-01-05T17:01:17","slug":"akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/","title":{"rendered":"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics"},"content":{"rendered":"- $30 million convertible note financing co-led by ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, and Westlake Village BioPartners expands investor base to include leading US life science venture capital firms\n\n\n\n- Clinical-stage NG-350A and NG-641 tumor gene therapies demonstrating consistent safety & tolerability profiles, as well as preliminary evidence of clinical activity in Phase 1 studies providing support for planned clinical PoC generation in future expansion cohorts\n\n\n- Relaunch represents critical next step in the ongoing corporate transformation which builds on Q3 2022 appointment of Howard Davis, Ph.D., as CEO and Q4 2022 establishment of US offices in Cambridge, Massachusetts\n\nCAMBRIDGE, Mass. & OXFO
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

– $30 million convertible note financing co-led by ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, and Westlake Village BioPartners expands investor base to include leading US life science venture capital firms – Clinical-stage NG-350A and NG-641 tumor gene therapies demonstrating consistent safety & tolerability profiles, as well as preliminary evidence of clinical activity in […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-849123","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nAkamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics - BeBeez\" \/>\n<meta property=\"og:description\" content=\"- $30 million convertible note financing co-led by ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, and Westlake Village BioPartners expands investor base to include leading US life science venture capital firms - Clinical-stage NG-350A and NG-641 tumor gene therapies demonstrating consistent safety & tolerability profiles, as well as preliminary evidence of clinical activity in […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-05T17:01:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics\",\"datePublished\":\"2023-01-05T17:01:17+00:00\",\"dateModified\":\"2023-01-05T17:01:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/\"},\"wordCount\":1259,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/\",\"name\":\"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2023-01-05T17:01:17+00:00\",\"dateModified\":\"2023-01-05T17:01:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics - BeBeez","og_description":"- $30 million convertible note financing co-led by ARCH Venture Partners, Parker Institute for Cancer Immunotherapy, and Westlake Village BioPartners expands investor base to include leading US life science venture capital firms - Clinical-stage NG-350A and NG-641 tumor gene therapies demonstrating consistent safety & tolerability profiles, as well as preliminary evidence of clinical activity in […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/","og_site_name":"BeBeez","article_published_time":"2023-01-05T17:01:17+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/"},"author":{"name":"","@id":""},"headline":"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics","datePublished":"2023-01-05T17:01:17+00:00","dateModified":"2023-01-05T17:01:17+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/"},"wordCount":1259,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/","name":"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2023-01-05T17:01:17+00:00","dateModified":"2023-01-05T17:01:17+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/akamis-bio-announces-30-million-financing-provides-clinical-program-update-and-relaunches-with-name-change-from-psioxus-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/849123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=849123"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/849123\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=849123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=849123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=849123"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=849123"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=849123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}